136 related articles for article (PubMed ID: 32187384)
41. Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation.
Mannis GN; Martin TG; Damon LE; Andreadis C; Olin RL; Kong KA; Faham M; Hwang J; Ai WZ; Gaensler KML; Sayre PH; Wolf JL; Logan AC
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1030-1036. PubMed ID: 26899561
[TBL] [Abstract][Full Text] [Related]
42. Improving minimal residual disease detection in precursor B-ALL based on immunoglobulin-kappa and heavy-chain gene rearrangements.
Sutton R; Bahar AY; Kwan E; Giles JE; Venn NC; Tran S; Hackenberg N; Pozza LD; Marshall GM; Haber M; van der Velden VH; Norris MD
Leukemia; 2008 Dec; 22(12):2265-7. PubMed ID: 18496559
[No Abstract] [Full Text] [Related]
43. Could cytogenetics and minimal residual disease replace conventional risk criteria in adults with Ph-negative acute lymphoblastic leukaemia?
Giebel S; Krawczyk-Kulis M; Kyrcz-Krzemien S; Haus O; Jagoda K; Piatkowska-Jakubas B; Paluszewska M; Seferynska I; Chrobok A; Stella-Holowiecka B; Kielbinski M; Holowiecki J
Br J Haematol; 2009 Mar; 144(6):970-2. PubMed ID: 19120362
[No Abstract] [Full Text] [Related]
44. The detection of minimal residual disease in acute lymphoblastic leukaemia.
Potter MN
Blood Rev; 1992 Jun; 6(2):68-82. PubMed ID: 1633509
[TBL] [Abstract][Full Text] [Related]
45. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
[TBL] [Abstract][Full Text] [Related]
46. Rearrangement patterns of immunoglobulin heavy chain (IgH) and light chain genes in acute lymphoblastic leukemia and chronic myelocytic leukemia lymphoid crisis cells showing oligoclonal IgH gene rearrangements.
Kawakami K; Kita K; Miwa H; Ikeda T; Nishii K; Masuya M; Morita N; Ohno T; Tanaka I; Nosaka T
Int J Hematol; 1992 Feb; 55(1):61-9. PubMed ID: 1581585
[TBL] [Abstract][Full Text] [Related]
47. Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia.
Heikamp EB; Pui CH
J Pediatr; 2018 Dec; 203():14-24.e2. PubMed ID: 30213460
[No Abstract] [Full Text] [Related]
48. Low frequency of clonotypic Ig and T-cell receptor gene rearrangements in t(4;11) infant acute lymphoblastic leukaemia and its implication for the detection of minimal residual disease.
Peham M; Panzer S; Fasching K; Haas OA; Fischer S; Marschalek R; Gadner H; Panzer-Grümayer ER
Br J Haematol; 2002 May; 117(2):315-21. PubMed ID: 11972513
[TBL] [Abstract][Full Text] [Related]
49. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia.
Pine SR; Wiemels JL; Jayabose S; Sandoval C
Leuk Res; 2003 Feb; 27(2):155-64. PubMed ID: 12526921
[TBL] [Abstract][Full Text] [Related]
50. Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis.
Beishuizen A; Verhoeven MA; Hählen K; van Wering ER; van Dongen JJ
Leukemia; 1993 Jun; 7(6):60-3. PubMed ID: 8315958
[TBL] [Abstract][Full Text] [Related]
51. [Identification of immunoglobulin and T-cell receptor gene rearrangements--prerequisite for monitoring of minimal residual disease in Polish acute lymphoblastic leukemia patients based on European standards. Preliminary results].
Dawidowska M; Derwich K; Szczepański T; Jółkowska J; Witt M; Wachowiak J
Med Wieku Rozwoj; 2006; 10(1 Pt 2):323-34. PubMed ID: 17028396
[TBL] [Abstract][Full Text] [Related]
52. Minimal residual disease in acute lymphoblastic leukaemia--PCR analysis of immunoglobulin gene rearrangements.
Cole-Sinclair M; Foroni L; Wright F; Mehta A; Prentice HG; Hoffbrand AV
Leuk Lymphoma; 1993; 11 Suppl 2():49-58. PubMed ID: 8124233
[TBL] [Abstract][Full Text] [Related]
53. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis.
Foroni L; Harrison CJ; Hoffbrand AV; Potter MN
Br J Haematol; 1999 Apr; 105(1):7-24. PubMed ID: 10366253
[No Abstract] [Full Text] [Related]
54. Paraneoplastic hypereosinophilic syndrome associated with IL3-IgH positive acute lymphoblastic leukemia.
Kobayashi K; Mizuta S; Yamane N; Ueno H; Yoshida K; Kato I; Umeda K; Hiramatsu H; Suehiro M; Maihara T; Usami I; Shiraishi Y; Chiba K; Miyano S; Adachi S; Ogawa S; Kiyokawa N; Heike T
Pediatr Blood Cancer; 2019 Jan; 66(1):e27449. PubMed ID: 30207070
[No Abstract] [Full Text] [Related]
55. Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease.
van der Velden VH; Szczepanski T; Wijkhuijs JM; Hart PG; Hoogeveen PG; Hop WC; van Wering ER; van Dongen JJ
Leukemia; 2003 Sep; 17(9):1834-44. PubMed ID: 12970784
[TBL] [Abstract][Full Text] [Related]
56. Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia.
Marshall GM; Kwan E; Haber M; Brisco MJ; Sykes PJ; Morley AA; Toogood I; Waters K; Tauro G; Ekert H
Leukemia; 1995 Nov; 9(11):1847-50. PubMed ID: 7475273
[TBL] [Abstract][Full Text] [Related]
57. Comparison of fluorescent consensus IgH PCR and allele-specific oligonucleotide probing in the detection of minimal residual disease in childhood ALL.
Owen RG; Goulden NJ; Oakhill A; Shiach C; Evans PA; Potter MN; Morgan GJ
Br J Haematol; 1997 May; 97(2):457-9. PubMed ID: 9163614
[TBL] [Abstract][Full Text] [Related]
58. Minimal/Measurable Residual Disease Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptor.
Tung JK; Jangam D; Ho CC; Fung E; Khodadoust MS; Kim YH; Zehnder JL; Stehr H; Zhang BM
J Mol Diagn; 2023 Jun; 25(6):331-341. PubMed ID: 36870603
[TBL] [Abstract][Full Text] [Related]
59. Development of acute lymphoblastic leukemia with IgH-EPOR in a patient with secondary erythrocytosis.
Sakamoto K; Tanaka S; Tomoyasu C; Tomii T; Yano M; Takagi K; Yasuhiko T; Uoshima N; Komatsu H; Imamura T
Int J Hematol; 2016 Dec; 104(6):741-743. PubMed ID: 27544511
[TBL] [Abstract][Full Text] [Related]
60. Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia.
Eckert C; Biondi A; Seeger K; Cazzaniga G; Hartmann R; Beyermann B; Pogodda M; Proba J; Henze G
Lancet; 2001 Oct; 358(9289):1239-41. PubMed ID: 11675066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
